Physician profile
James E Cevallos
NPI 1720181829
$663.61
in general payments reported to CMS, 2019-2025
11 companies · $49.50 in 2025
The $49.50 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $24.47 · 2021: $43.80 · 2022: $300 · 2024: $16.77 · 2025: $49.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $66.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $66.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $189.20 | 2022 | |
| Novo Nordisk INC | $142.55 | 2019-2022 | |
| Biotronik INC. | $98.46 | 2019 | |
| Merck Sharp & Dohme LLC | $79.44 | 2019-2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Lilly USA, LLC | $52.39 | 2019-2024 | Zepbound |
| Bioventus LLC | $26.36 | 2021 | |
| Coopersurgical, INC. | $18.67 | 2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $17.46 | 2019 | |
| Phadia US INC. | $14.44 | 2019 | |
| Exact Sciences Corporation | $13.68 | 2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cevallos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.